BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

855 related articles for article (PubMed ID: 15790607)

  • 1. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.
    Petta CA; Ferriani RA; Abrao MS; Hassan D; Rosa E Silva JC; Podgaec S; Bahamondes L
    Hum Reprod; 2005 Jul; 20(7):1993-8. PubMed ID: 15790607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
    Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea.
    Bahamondes L; Petta CA; Fernandes A; Monteiro I
    Contraception; 2007 Jun; 75(6 Suppl):S134-9. PubMed ID: 17531605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue.
    Bayoglu Tekin Y; Dilbaz B; Altinbas SK; Dilbaz S
    Fertil Steril; 2011 Feb; 95(2):492-6. PubMed ID: 20883991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue.
    Ferreira RA; Vieira CS; Rosa-E-Silva JC; Rosa-e-Silva AC; Nogueira AA; Ferriani RA
    Contraception; 2010 Feb; 81(2):117-22. PubMed ID: 20103448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of levonorgestrel-releasing intrauterine system in treatment of recurrent endometriosis after conservative surgery].
    Xu XW; Zhang YW; He FF; Wang LD; Guan YT; Sun J; Lin M; Hu Y
    Zhonghua Fu Chan Ke Za Zhi; 2011 Apr; 46(4):250-4. PubMed ID: 21609576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
    Sheng J; Zhang WY; Zhang JP; Lu D
    Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
    Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
    Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower abdominal pain and back pain among women treated for menorrhagia: a five-year randomized controlled trial.
    Heliövaara-Peippo S; Halmesmäki K; Hurskainen R; Teperi J; Grenman S; Kivelä A; Kujansuu E; Tuppurainen M; Vuorma S; Yliskoski M; Paavonen J
    Acta Obstet Gynecol Scand; 2009; 88(12):1389-96. PubMed ID: 19878089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Levonorgestrel-releasing intrauterine system and combined oral contraceptives as conservative treatments for recurrent ovarian endometriosis: a comparative clinical study].
    Xu XW; Wang LD; Zhu XQ; Yan LZ; Guan YT; Zhu SC; Hu Y
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(15):1047-50. PubMed ID: 21609640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a role for use of levonorgestrel intrauterine system in women with chronic pelvic pain?
    Anpalagan A; Condous G
    J Minim Invasive Gynecol; 2008; 15(6):663-6. PubMed ID: 18774757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the hemostatic effects of a levonorgestrel-releasing intrauterine system and leuprolide acetate in women with endometriosis: a randomized clinical trial.
    Yamaguti EM; Brito MB; Ferriani RA; Garcia AA; Rosa-e-Silva JC; Vieira CS
    Thromb Res; 2014 Dec; 134(6):1193-7. PubMed ID: 25283586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis.
    Lan S; Ling L; Jianhong Z; Xijing J; Lihui W
    J Int Med Res; 2013 Jun; 41(3):548-58. PubMed ID: 23660087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium.
    Gomes MK; Rosa-e-Silva JC; Garcia SB; de Sá Rosa-e-Silva AC; Turatti A; Vieira CS; Ferriani RA
    Hum Reprod; 2009 Nov; 24(11):2736-45. PubMed ID: 19661125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Levonorgestrel-releasing intrauterine system for treatment of dysmenorrhea associated with adenomyosis].
    Sheng J; Lu D; Zhang JP; Cui GF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):467-70. PubMed ID: 17083813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial.
    Carvalho N; Margatho D; Cursino K; Benetti-Pinto CL; Bahamondes L
    Fertil Steril; 2018 Nov; 110(6):1129-1136. PubMed ID: 30396557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Add-back therapy in the treatment of endometriosis-associated pain.
    Zupi E; Marconi D; Sbracia M; Zullo F; De Vivo B; Exacustos C; Sorrenti G
    Fertil Steril; 2004 Nov; 82(5):1303-8. PubMed ID: 15533351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up.
    Lockhat FB; Emembolu JO; Konje JC
    Hum Reprod; 2005 Mar; 20(3):789-93. PubMed ID: 15608040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
    Busfield RA; Farquhar CM; Sowter MC; Lethaby A; Sprecher M; Yu Y; Sadler LC; Brown P; Johnson N
    BJOG; 2006 Mar; 113(3):257-63. PubMed ID: 16487195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.